The pharmacokinetics of aspirin in rats and the effect of buffer
- PMID: 2013838
- DOI: 10.1007/BF01073867
The pharmacokinetics of aspirin in rats and the effect of buffer
Abstract
Aspirin (acetylsalicyclic acid) was administered to rats intravenously, orally, and intraintestinally at different doses or in different dosage forms. The distribution and elimination kinetics of aspirin in rats following intravenous administration were best described by a two-compartmental open system and were dose independent up to 15 mg/kg. The terminal elimination half-life following intravenous dosing (10 mg/kg) was 3.36 +/- 0.85 min (n = 15) with the clearance being 8.40 +/- 1.24 L/(kg.hr). Intravenous distribution and elimination kinetics of aspirin in rats were not influenced by an orally administered buffered solution with a buffer capacity of 0.933 mEq ANC (acid neutralizing capacity) per kg of body weight. However, this orally buffered solution did change the gastrointestinal absorption kinetics of aspirin in rats. The absolute bioavailable dose of aspirin was 56.6 +/- 10.4% (n = 6) following its administration in an unbuffered solution while it was only 31.8 +/- 8.0% (n = 6) following administration in the buffered solution. The corresponding values of the absolute bioavailable doses were 43.4 +/- 3.7% and 25.5 +/- 1.8% following intraintestinal administration. The lower systemic availability of aspirin in the presence of buffer is attributed to a greater fraction of the administered dose becoming available for absorption from the intestine where the extraction efficiency is higher than that in the stomach.
Similar articles
-
Kinetics of aspirin, salicylic acid, and salicyluric acid following oral administration of aspirin as a tablet and two buffered solutions.J Pharm Sci. 1981 Mar;70(3):262-5. doi: 10.1002/jps.2600700308. J Pharm Sci. 1981. PMID: 7264888
-
Disposition of single-dose intravenous and oral aspirin in children.Dev Pharmacol Ther. 1991;17(3-4):180-6. doi: 10.1159/000457520. Dev Pharmacol Ther. 1991. PMID: 1841835
-
Influence of food on aspirin absorption from tablets and buffered solutions.J Pharm Sci. 1983 Jul;72(7):819-21. doi: 10.1002/jps.2600720727. J Pharm Sci. 1983. PMID: 6886992
-
Pharmacokinetics of low-dose oral modified release, soluble and intravenous aspirin in man, and effects on platelet function.Eur J Clin Pharmacol. 1988;35(3):287-94. doi: 10.1007/BF00558267. Eur J Clin Pharmacol. 1988. PMID: 3181281
-
Comparative aspirin absorption kinetics after administration of sodium- and potassium-containing buffered solutions.J Pharm Sci. 1984 Jul;73(7):998-9. doi: 10.1002/jps.2600730737. J Pharm Sci. 1984. PMID: 6470971
Cited by
-
Induction of paraoxonase 1 and apolipoprotein A-I gene expression by aspirin.J Lipid Res. 2008 Oct;49(10):2142-8. doi: 10.1194/jlr.M800082-JLR200. Epub 2008 Jun 2. J Lipid Res. 2008. PMID: 18519978 Free PMC article.
-
The intact nephron hypothesis as a model for renal drug handling.Eur J Clin Pharmacol. 2019 Feb;75(2):147-156. doi: 10.1007/s00228-018-2572-8. Epub 2018 Oct 8. Eur J Clin Pharmacol. 2019. PMID: 30298363
-
New approaches for the assessment of platelet activation status in thrombus under flow condition using confocal microscopy.Naunyn Schmiedebergs Arch Pharmacol. 2020 Apr;393(4):727-738. doi: 10.1007/s00210-019-01789-x. Epub 2019 Dec 13. Naunyn Schmiedebergs Arch Pharmacol. 2020. PMID: 31834466
-
Development and Pharmacokinetics of a Novel Acetylsalicylic Acid Dry Powder for Pulmonary Administration.Pharmaceutics. 2022 Dec 15;14(12):2819. doi: 10.3390/pharmaceutics14122819. Pharmaceutics. 2022. PMID: 36559312 Free PMC article.
-
Synthesis, Characterization, and Application of 2-((3-(Chloromethyl)-benzoyl)oxy)benzoic Acid: A Review.ACS Omega. 2022 Dec 28;8(1):42-47. doi: 10.1021/acsomega.2c05566. eCollection 2023 Jan 10. ACS Omega. 2022. PMID: 36643478 Free PMC article. Review.